Cargando…
715. Bulgecin A lowers Imipenem MICs in Clinical MDR Acinetobacter baumannii (ACB) Strains
BACKGROUND: Genetic screening of ACB has revealed genes that confer increased susceptibility to β-lactams when these genes are disrupted suggesting novel drug targets. One such target is lytic transglycosylase, LT. Bulgecin A (BlgA) is a natural product of Paraburkholderia acidophila and an LT inhib...
Autores principales: | Skalweit, Marion J, Rojas, Laura J, Bonomo, Robert A, Dik, David A, Tomoshige, Shusuke, Mobashery, Shahriar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811142/ http://dx.doi.org/10.1093/ofid/ofz360.783 |
Ejemplares similares
-
Total Syntheses of Bulgecins A, B, and C and Their
Bactericidal Potentiation of the β-Lactam Antibiotics
por: Tomoshige, Shusuke, et al.
Publicado: (2018) -
Penetration through Outer Membrane and Efflux Potential in Pseudomonas aeruginosa of Bulgecin A as an Adjuvant to β-Lactam Antibiotics
por: Kim, Choon, et al.
Publicado: (2023) -
Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms
por: Skalweit, Marion J, et al.
Publicado: (2016) -
Transcriptome profiling in imipenem-selected Acinetobacter baumannii
por: Chang, Kai-Chih, et al.
Publicado: (2014) -
Whole-Genome Shotgun Sequencing of Two β-Proteobacterial
Species in Search of the Bulgecin Biosynthetic Cluster
por: Horsman, Mark E., et al.
Publicado: (2017)